This document is an excerpt from the EUR-Lex website
Document 22007D0080
Decision of the EEA Joint Committee No 80/2007 of 6 July 2007 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 80/2007 of 6 July 2007 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 80/2007 of 6 July 2007 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
OJ L 328, 13.12.2007, p. 19–20
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) This document has been published in a special edition(s)
(HR)
In force
13.12.2007 |
EN |
Official Journal of the European Union |
L 328/19 |
DECISION OF THE EEA JOINT COMMITTEE
No 80/2007
of 6 July 2007
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,
Whereas:
(1) |
Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 12/2007 of 27 April 2007 (1). |
(2) |
Commission Regulation (EC) No 1729/2006 of 23 November 2006 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib and triclabendazole (2) is to be incorporated into the Agreement. |
(3) |
Commission Regulation (EC) No 1805/2006 of 7 December 2006 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards thiamphenicol, fenvalerate and meloxicam (3) is to be incorporated into the Agreement. |
(4) |
Commission Regulation (EC) No 1831/2006 of 13 December 2006 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards Doramectin (4) is to be incorporated into the Agreement, |
HAS DECIDED AS FOLLOWS:
Article 1
The following indents shall be added in point 14 (Council Regulation (EEC) No 2377/90) of Chapter XIII of Annex II to the Agreement:
‘— |
32006 R 1729: Commission Regulation (EC) No 1729/2006 of 23 November 2006 (OJ L 325, 24.11.2006, p. 6), |
— |
32006 R 1805: Commission Regulation (EC) No 1805/2006 of 7 December 2006 (OJ L 343, 8.12.2006, p. 66), |
— |
32006 R 1831: Commission Regulation (EC) No 1831/2006 of 13 December 2006 (OJ L 354, 14.12.2006, p. 5).’ |
Article 2
The texts of Regulations (EC) No 1729/2006, (EC) No 1805/2006 and (EC) No 1831/2006 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 7 July 2007, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 6 July 2007.
For the EEA Joint Committee
The President
Stefán Haukur JÓHANNESSON
(1) OJ L 209, 9.8.2007, p. 20.
(2) OJ L 325, 24.11.2006, p. 6.
(3) OJ L 343, 8.12.2006, p. 66.
(4) OJ L 354, 14.12.2006, p. 5.
(*1) No constitutional requirements indicated.